Verve Pauses Enrollment in Base Editing Trial after Adverse Events.

Alex Philippidis

Published in: Human gene therapy (2024)

Keyphrases

crispr cas
phase iii
study protocol
phase ii
clinical trial
health insurance
randomized controlled trial
open label
affordable care act